Drug-induced nail disorders - Incidence, management and prognosis

被引:45
|
作者
Piraccini, BM [1 ]
Tosti, A [1 ]
机构
[1] Univ Bologna, Dept Dermatol, I-40136 Bologna, Italy
关键词
D O I
10.2165/00002018-199921030-00004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A large number of drugs of different classes, ranging from antibacterials to chemotherapeutic agents to psoralens, can be responsible for the development of nail changes. Drug-induced nail changes usually involve several or all 20 nails and appear in temporal correlation with drug intake. Some nail changes are asymptomatic and only cause cosmetic problems, while others cause pain and discomfort and impair manual activities or deambulation. Drug-induced nail abnormalities are usually transitory and disappear with drug withdrawal, but sometimes persist in time. The pathogenesis of the nail changes is usually a toxic effect of the drug on the different nail constituents. but other mechanisms can be involved. Drugs that are well known to produce nail abnormalities include cancer chemotherapeutic agents, psoralens, retinoids, tetracyclines, antimalarials and zidovudine. Arsenic poisoning is also always associated with nail changes that have medico-legal importance. Some drugs taken during pregnancy may impair nail development of the fetus, and nail hypoplasia or other nail dystrophies will be evident in the newborn.
引用
收藏
页码:187 / 201
页数:15
相关论文
共 50 条
  • [21] DRUG-INDUCED DEPRESSION - INCIDENCE, AVOIDANCE AND MANAGEMENT
    PATTEN, SB
    LOVE, EJ
    DRUG SAFETY, 1994, 10 (03) : 203 - 219
  • [22] Drug-Induced Movement Disorders: Emergencies and Management
    Robottom, Bradley J.
    Shulman, Lisa M.
    Weiner, William J.
    NEUROLOGIC CLINICS, 2012, 30 (01) : 309 - +
  • [23] DRUG-INDUCED PSYCHIATRIC-DISORDERS AND THEIR MANAGEMENT
    HOLLISTER, LE
    MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (06): : 428 - 448
  • [24] Drug-induced urinary retention - Incidence, management and prevention
    Verhamme, Katia M. C.
    Sturkenboom, Miriam C. J. M.
    Stricker, Bruno H. Ch
    Bosch, Ruud
    DRUG SAFETY, 2008, 31 (05) : 373 - 388
  • [25] Drug-Induced Oesophageal DisordersPathogenesis, Incidence, Prevention and Management
    Daniel Jaspersen
    Drug Safety, 2000, 22 : 237 - 249
  • [26] Drug-Induced Parkinsonism in the Elderly Incidence, Management and Prevention
    Luis Lopez-Sendon, Jose
    Angeles Mena, Maria
    Garcia de Yebenes, Justo
    DRUGS & AGING, 2012, 29 (02) : 105 - 118
  • [27] Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management
    Fang, Fang
    Sun, Hongwei
    Wang, Zuowei
    Ren, Ming
    Calabrese, Joseph R.
    Gao, Keming
    CNS DRUGS, 2016, 30 (09) : 845 - 867
  • [28] Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management
    Fang Fang
    Hongwei Sun
    Zuowei Wang
    Ming Ren
    Joseph R. Calabrese
    Keming Gao
    CNS Drugs, 2016, 30 : 845 - 867
  • [29] Psychotropic drug-induced priapism - Incidence, mechanism and management
    Weiner, DM
    Lowe, FC
    CNS DRUGS, 1998, 9 (05) : 371 - 379
  • [30] Drug-induced cardiac arrhythmias - Incidence, prevention and management
    Doig, JC
    DRUG SAFETY, 1997, 17 (04) : 265 - 275